At the forefront of neurological innovation, Neurostimulation Devices companies specialize in creating cutting-edge technologies. Their expertise lies in developing implantable and non-invasive devices that employ neurostimulation techniques. These advancements offer therapeutic solutions for conditions such as chronic pain, epilepsy, and movement disorders, providing new avenues for patient care.
Boston Scientific acquires NeuroPace for $825 million deal strengthens Boston Scientific's position in the deep brain stimulation (DBS) market, giving them access to NeuroPace's novel RNS® system for epilepsy treatment.
Abbott acquires St. Jude Medical for $30 billion mega-deal expands Abbott's reach in the spinal cord stimulation (SCS) market, adding St. Jude Medical's innovative portfolio of SCS devices to their offerings.
on-invasive brain stimulation for mental health Research is exploring the use of transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) for treating conditions like depression and anxiety, offering less invasive alternatives to traditional therapy.
Bioresorbable neurostimulation devices Companies like NeuroPace are developing implants that dissolve over time, potentially reducing risks associated with permanent implant removal.
List of Neurostimulation Devices Key Companies in the Market
Neurostimulation Devices Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)